T
he top-selling drug in the US is not Viagra. It’s not Ambien. It’s not Prozac. No, it’s Abilify, an anti-psychotic used primarily to treat bipolar disorder and secondarily to treat depression.
The prescription medication boasts sales figures of 6.9 billion dollars a year. From April 2013 through March 2014, Abilify sold $6,885,243,368, more than all anti-depressants combined according to the Daily Beast.
Who among us is on Abilify? What are your experiences? I threw up within 20 minutes of taking it. It’s not for me. Is it the miracle drug its proponents claim it to be? Leave your comment below.
Head Writer
Conor Bezane is a music-meister who has written for MTV News, AOL, and VICE. He is a recovering bipolar addict who can be found digging through the crates at a local record store when he’s not attacking his keyboard, writing nonfiction. His first book, The Bipolar Addict, is available now on Amazon.
